Biotechnology

Significant progress has been made in the run up to change negotiations in Paris this month, but where are the investment opportunities that will benefit from reducing carbon emissions? Alliance Trust's Mike Appleby explores the implications for investors...

Impact of digital technology and price pressures

Recognise boutiques and passive investing

Fund outperforms index over month

Why has performance suffered this year?

Geoffrey C. Hsu, partner of OrbiMed and manager of the BiotechGrowth trust, assesses the key drivers for the sector in 2016 and beyond.

Focus on high quality companies

Industry poses inherent risks

Manager increases positions on weakness

Grant Bowers, manager of the Franklin US Opportunities fund, takes a closer look at the drivers for the healthcare and tech sectors.